Organized by the International Cell Senescence Association (ICSA), the foremost global scientific society for cellular senescence research, this conference serves as a platform for cutting-edge discussions and scientific collaborations. The event aligns with the mission to bridge academia, industry, and regulatory bodies, setting rigorous scientific and ethical standards for the rapidly evolving field of longevity research.

EVENT HIGHLIGHTS

Keynote Sessions & Expert Panels

• World-renowned researchers and industry leaders will present on cutting-edge topics, including the molecular mechanisms of senescence, novel therapeutic targets, and translational strategies for clinical application.

Interactive Workshops

• Hands-on sessions providing exposure to the latest technologies and methodologies in senescence research and therapeutic development.

Networking & Collaboration Opportunities

• Curated events designed to connect scientists, clinicians, investors, and policymakers, fostering interdisciplinary partnerships that drive innovation

WHO SHOULD ATTEND?

The conference will bring together a diverse audience, including:

• Academic Researchers – Scientists investigating the fundamental biology of aging and cellular senescence
• Biotechnology and Pharmaceutical Professionals – Experts leading the development of senotherapeutic interventions
• Healthcare Providers – Clinicians interested in the translational application of senescence-targeting therapies
• Investors and Venture Capitalists – Stakeholders exploring opportunities in the rapidly growing longevity biotech sector
• Regulatory Authorities – Policymakers addressing the ethical and regulatory frameworks surrounding emerging longevity therapies

With this multidisciplinary group, ICSA Conference 2026 aims to catalyze transformative breakthroughs that will shape the future of healthy aging and age-related disease intervention.